Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esmya (ulipristal)
Pharma
How can AbbVie win FTC backing for Allergan buy?
In light of increased antitrust scrutiny over pharma M&A, AbbVie will also cut a few products to win U.S. clearance for its Allergan buyout.
Angus Liu
Jun 26, 2019 11:35am
AbbVie puts endometriosis options on display in Orilissa ad
Jan 23, 2019 8:27am
Allergan's Esmya rejection dents women's health sale prospects
Aug 22, 2018 9:48am
Allergan might just have an activist fight on its hands
May 18, 2018 11:40am
FDA delays verdict on Allergan's Esmya
Mar 1, 2018 11:34am
EMA nixes new Esmya patients as liver-safety probe continues
Feb 12, 2018 12:00pm
